---
search:
  boost: 3
---

# Antifungals

This is a subcategory of Topical Agents.

## Decision Trees

- [Topical - Antifungals - Butenafine, Ciclopirox Kit, Ertaczo, Ketoconazole Foam, Luliconazole, Miconazole/Zinc Oxide/White Petrolatum Oint, Naftifine, Oxiconazole, Tavaborole](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNE1TMlVOVVc1NlRTSUYwRlVSSVM5MjRTNSQlQCN0PWcu){:target="_blank" rel="noopener"}

- [Topical - Antifungals - Jublia](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUMEI0QzNPTkxRV1dLM0lOTDQxOU5VWlg1WSQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                    | Generic Name | Quantity | Time (Days) |
| :--------------------------- | :----------- | :------: | :---------: |
| Alevazol                     |              |          |             |
| Ciclopirox                   |              |          |             |
| Clotrimazole                 |              |          |             |
| Clotrimazole / Betamethasone |              |          |             |
| Econazole                    |              |          |             |
| Ketoconazole                 |              |          |             |
| Miconazole                   |              |          |             |
| Nystatin                     |              |          |             |
| Nystatin / Triamcinolone     |              |          |             |
| Terbinafine                  |              |          |             |
| Tolnaftate                   |              |          |             |

### Non-Preferred

| Non-Preferred                                   | Generic Name | Quantity | Time (Days) |
| :---------------------------------------------- | :----------- | :------: | :---------: |
| Butenafine                                      |              |          |             |
| Ciclopirox Kit                                  |              |          |             |
| Ertaczo                                         |              |          |             |
| Jublia                                          |              |          |             |
| Ketoconazole Foam                               |              |          |             |
| Luliconazole                                    |              |          |             |
| Miconazole / Zinc Oxide / White Petrolatum Oint |              |          |             |
| Naftifine                                       |              |          |             |
| Oxiconazole                                     |              |          |             |
| Tavaborole                                      |              |          |             |

## Authorizations

**Length of Authorizations**: Up to 180 days for all agents except 365 days for Jubila

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response to at least **14 days** with at least **two preferred** drugs, if indicated for diagnosis
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Efinaconazole (Jublia)

Additional Efinaconazole (Jublia) Criteria

Must have had an inadequate clinical response of at least **365 days** with at least **one preferred** topical drug AND at least **84 days** with at least **one preferred** oral drug indicated for diagnosis

### Additional Information

- Requests may be authorized if:
    - The infection is caused by an organism resistant to preferred antibiotics drugs (note diagnosis and any culture/sensitivity results)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=100&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} 

[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001+UPDL+Criteria+_v2.FINAL.pdf#page=102){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20231001_UPDL_V2.FINAL.hyperlinks_added.pdf#page=32){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
